SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Shib2's story is nothing short of extraordinary, a tale of mystery, transformation, unity, and the unwavering determination of its community.  The Enigmatic Origins  Shib2 was born from the vision of a reclusive developer, known only by the pseudonym "Cipher." Unlike many cryptocurrency projects that begin with a whitepaper and a team of experts, Shib2 emerged quietly and mysteriously. Cipher, shrouded in anonymity, released the project's smart contract on the Ethereum blockchain with little fanfare. There were no pre-sales, no flashy marketing campaigns – just a single post on a cryptocurrency forum.  A Humble Beginning  In the early days, Shib2 was nothing more than a curiosity. Its smart contract was simple, allowing users to exchange Ethereum for Shib2 tokens. The project lacked a clear roadmap or a well-defined purpose, leaving many in the crypto community skeptical. Yet, something about Shib2 intrigued a small group of early adopters who saw its potential.  The Power of Community  What truly sets Shib2 apart is its community. As more people discovered the project, they formed a tight-knit group of enthusiasts. They began discussing its possibilities, proposing ideas, and volunteering their skills to help the project grow. Shib2 was no longer just Cipher's creation; it had become a collective endeavor.  Innovation and Transformation  The early days of Shib2 were marked by a rapid evolution. The community, driven by a desire to make Shib2 more than just a simple token, started developing new features and use cases. They introduced decentralized applications (dApps) that utilized Shib2, ranging from decentralized exchanges to governance platforms.  One of the project's standout features was the Shib2 NFT marketplace, where artists and creators could mint and trade non-fungible tokens. This marketplace quickly gained traction and became a hub for digital artists looking to explore the blockchain space.  Challenges and Growth  Of course, Shib2's journey was not without its challenges. The project faced its fair share of security issues and technical hurdles. Yet, the community's resilience shone through as they collectively tackled these obstacles. Audits were conducted, developers collaborated, and improvements were made. Shib2's journey was marked by a relentless pursuit of innovation and security.  Shib2 Today  Today, Shib2 stands as a testament to the power of community-driven projects. It has grown beyond anyone's expectations, boasting a thriving ecosystem of dApps, a robust NFT marketplace, and a dedicated community that continues to push the boundaries of what is possible in the world of blockchain technology.  Cipher, the enigmatic founder, still remains elusive, but their creation, Shib2, has taken on a life of its own. It has become a symbol of the potential for innovation, transformation, and unity within the cryptocurrency space.

SHIB2.0

SHIB2 is trending as community members discuss its volatile price action and potential for high rewards, with some comparing it to the original SHIB. Some users are talking about accumulating more while it's still early, viewing it as a second chance to capture the gains of its predecessor. The coin's increasing number of holders and growing market capitalization are also being highlighted.

Global X Funds - Global X DAX Germany ETF

Global X DAX Germany ETF

The Global X DAX Germany ETF ($DAX) is trending due to technical analysis suggesting strong buying opportunities and reactions at specific price levels, particularly around a "Blue Box" area. Community discussions revolve around the Elliott Wave theory and potential moves based on these technical indicators. Despite some concerns about economic growth, particularly in Germany, the ETF has recently hit new highs, bolstering bullish sentiment.

Orca is the most user-friendly DEX on Solana.  Orca is one of the first general-purpose AMMs launched on Solana. Users can swap assets, provide liquidity, and earn yield through an easy-to-use interface. Projects can use Orca as a money-lego to easily integrate swapping, farming, or on-chain data into their dApp.  Orca strives to provide easy and effective financial tools for everyone, bringing DeFi to the masses.

Orca

$ORCA is trending as traders discuss recent integrations that could supercharge its reach within the Solana DeFi ecosystem; bullish sentiment is fueled by a DAO-approved buyback program and staking incentives. However, some traders caution about potential manipulation and sinister bidding, while others point to a Bybit hack potentially contributing to recent volatility.

FLOKI is the utility token of the Floki Ecosystem. The Floki Ecosystem is a community-powered ecosystem that aims to give people control of their finances through four key utility offerings:  - The Valhalla NFT Metaverse Game. - The Floki University Crypto Education platform. - DeFi. - The FlokiPlaces NFT & Merchandise Marketplace.

Floki Token

Floki is trending as the community anticipates a marketing announcement and discusses potential integration with Elon Musk's ventures, sparking excitement about a possible surge. Traders are analyzing Floki's structure and potential for a squeeze, while some express frustration with recent price action. Community members also highlight the trading bot and staking rewards.

Harvest automatically farms the highest yields in DeFi

Harvest Finance

Harvest Finance ($FARM) is gaining attention as traders note its low circulating supply and potential for significant price movement. Community members are discussing technical indicators suggesting a possible breakout, with some anticipating a rapid surge. The recent Arbitrum DAO approval for yield farming incentives is also a key point of interest for the coin.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

Chainlink is trending as investors assess its role in the evolving landscape of real-world asset tokenization and decentralized finance. Community discussions revolve around its robust data oracles, cross-chain interoperability, and recent partnerships, as well as potential competition from Keeta.  The focus is on LINK's long-term utility and value accrual within the broader crypto ecosystem, especially considering its position as a core infrastructure component.

MGM Resorts International is a holding company, which engages in the ownership and operations of casino resorts. The firm's casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. It operates through the following business segments: Las Vegas Strip Resorts, Regional Operations, MGM China, and MGM Digital. The Las Vegas Strip Resorts segment operates the following casino resorts: Bellagio, MGM Grand Las Vegas, Mandalay Bay, The Mirage, Luxor, New York-New, Excalibur, Park MGM, and Circus Las Vegas. The Regional Operations segment consists of the following casino resorts: MGM Grand Detroit in Detroit, Michigan, Beau Rivage in Biloxi, Mississippi, Gold Strike Tunica in Tunica, Mississippi, Borgata in Atlantic City, New Jersey, MGM National Harbor in Prince George’s County, Maryland, and MGM Springfield in Springfield, Massachusetts. The MGM China segment includes MGM Macau and MGM Cotai. The MGM Digital segment focuses on the online gaming portfolio, which consists primarily of Leo Vegas, which is headquartered in Sweden and Malta. The company was founded by Kerkor Kerkorian on January 29, 1986 and is headquartered in Las Vegas, NV.

MGM Resorts International

MGM is trending following positive Q4 results and strong 2025 guidance, with significant growth in Macau and digital operations. The company's announcement of a substantial $2 billion buyback program has boosted investor confidence. Community discussions focus on the stock's potential for further gains, despite some analysts adjusting price targets.

Talen Energy Corp. engages in the operation of power infrastructure. It produces and sells electricity, capacity, and ancillary services into wholesale power markets through its subsidiaries. The company was founded on July 2, 2014 and is headquartered in Houston, TX.

Talen Energy Corp - Ordinary Shares New

Talen Energy Corp

Talen Energy Corp ($TLN) is trending amid discussions of its strategic positioning within the energy sector, particularly regarding AI data centers. Recent option activity and analyst ratings suggest growing bullish sentiment, while community members discuss its potential for explosive growth and possible acquisition. The stock's movements are also being tied to broader trends in the energy sector and nuclear power.

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

PTC Therapeutics Inc

PTC Therapeutics is trending due to a mix of analyst target price adjustments and reactions to recent news, including an FDA rejection of a treatment, which Citi analysts weren't surprised by. The community is actively discussing pipeline catalysts, upcoming earnings, and potential accelerated approval pathways, especially around their Huntington's disease drug, while noting some volatility around FDA decisions and analyst ratings. Option activity indicates bullish sentiment, with significant call buying.

SPDR Series Trust - State Street SPDR S&P Retail ETF

SPDR S&P Retail ETF

The SPDR S&P Retail ETF ($XRT) is trending due to discussions around the strength of the consumer and the upcoming retail earnings season, with some analysts highlighting potential breakouts while others express concerns about consumer spending habits and debt. Community members are closely watching key price levels and technical indicators, speculating about potential short squeezes and the impact of broader market trends. There is also discussion on specific companies within the XRT, like GameStop and Chewy, and how their performance influences the ETF's overall movement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$ENSC just announced its Annual Meeting — Dec 23 (virtual) — and the agenda reveals some major structural issues worth watching: 
• Proposal 1: approval to issue shares + warrants to a new investor. If passed, it could materially increase share count and dilute current holders. 
• Proposal 2: amendment of the Omnibus Incentive Plan — increasing eligible shares from ~121K to ~721K — showing the company is preparing for talent/incentive needs. 
• Proposals 3 &amp; 4: board elections + auditor ratification — important, but less volatile than the issuance issues. 
Why you should care: this isn’t about clinical data — it’s about governance, funding, and dilution. Owning shares in a biotech means your exposure is not only to “will the drug work,” but also “will the company have enough cash, and how will it treat existing shareholders when it raises?” 
This meeting is a reminder: dilution risk is real. For long-term investors, that means: keep the science in view, but don’t ignore the stock math.

No Pain No Gain

mrsparex

A Brave Lion

BigZack

SXAVI

StockTwits Web

Ensysce Biosciences Inc

 just announced its Annual Meeting — Dec 23 (virtual) — and the agenda reveals some major structural issues worth watching: 
• Proposal 1: approval to issue shares + warrants to a new investor. If passed, it could materially increase share count and dilute current holders. 
• Proposal 2: amendment of the Omnibus Incentive Plan — increasing eligible shares from ~121K to ~721K — showing the company is preparing for talent/incentive needs. 
• Proposals 3 & 4: board elections + auditor ratification — important, but less volatile than the issuance issues. 
Why you should care: this isn’t about clinical data — it’s about governance, funding, and dilution. Owning shares in a biotech means your exposure is not only to “will the drug work,” but also “will the company have enough cash, and how will it treat existing shareholders when it raises?” 
This meeting is a reminder: dilution risk is real. For long-term investors, that means: keep the science in view, but don’t ignore the stock math.

CLEIDIR MATEINE DE LIMA

@Mateine Do you think the price of the stock will go down further?

 Do you think the price of the stock will go down further?

DeUrker

@DeUrker — Short answer: it could, but not for the reason most people think. The current pressure isn’t about science — it’s about the upcoming Annual Meeting and the proposed share issuance. Markets usually price in dilution before it happens, which creates volatility and overshooting on the downside. 
 
That said, biotech bottoms often form when fear of dilution peaks. If the company raises capital on reasonable terms or the vote outcome is better than expected, sentiment can flip quickly. 
 
So yes, more downside is possible in the near term, but it’s driven by mechanics, not fundamentals. Long-term direction still depends on clinical execution, not today’s panic.

 — Short answer: it could, but not for the reason most people think. The current pressure isn’t about science — it’s about the upcoming Annual Meeting and the proposed share issuance. Markets usually price in dilution before it happens, which creates volatility and overshooting on the downside. 
 
That said, biotech bottoms often form when fear of dilution peaks. If the company raises capital on reasonable terms or the vote outcome is better than expected, sentiment can flip quickly. 
 
So yes, more downside is possible in the near term, but it’s driven by mechanics, not fundamentals. Long-term direction still depends on clinical execution, not today’s panic.

@Mateine Thank you very much for your response. In any case, it is striking that they want to adjust the reward structure. This seems to suggest that the management wants to project confidence or that something is about to happen.

 Thank you very much for your response. In any case, it is striking that they want to adjust the reward structure. This seems to suggest that the management wants to project confidence or that something is about to happen.